Annovis Bio (ANVS) Other Non-Current Assets (2019 - 2026)
Annovis Bio's Other Non-Current Assets was $7,495 in Q2 2026, unchanged from $7,495 a year earlier and unchanged from the prior quarter.
Powered by 
Analysis
Annovis Bio (ANVS) Other Non-Current Assets (2019 - 2026) Analysis & Trends
From Q4 2019 onward, Annovis Bio has reported Other Non-Current Assets for 27 quarters.
- Other Non-Current Assets shows a five-year compound annual growth rate of 3.1% (FY2020 to FY2025).
- In earlier years, Other Non-Current Assets was $7,495 in FY2024 (-64.0%), $20,796 in FY2023 (+85.1%), $11,238 in FY2022 (+13.9%) and $9,865 in FY2021 (+53.1%).
- Quarterly Other Non-Current Assets has moved between $5,796 (Q1 2024) and $26,022 (Q2 2023) over five years.
- Compared with a year earlier, Other Non-Current Assets was higher in 1 of the last eight quarters, with an average decline of 12.3%.
- The best year-over-year quarter for Other Non-Current Assets over five years was Q2 2023 (growth of 151.3%); the worst was Q2 2024 (a decline of 71.2%).
- Per Business Quant data, ANVS's Other Non-Current Assets in the three quarters before Q2 2026 was $7,495 (Q1 2026), $7,495 (Q4 2025) and $7,495 (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Other Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 14.27 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | 10.73 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 19.60 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | 5.93 Bn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | - |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 12.98 Bn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | 4.75 Bn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | 9.94 Bn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 1.25 Bn |
| 10 | Annovis Bio | 54.11 Mn | 54.11 Mn | - | 7,495.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 7,495.00 |
| Mar 31, 2026 | 7,495.00 |
| Dec 31, 2025 | 7,495.00 |
| Sep 30, 2025 | 7,495.00 |
| Jun 30, 2025 | 7,495.00 |
| Mar 31, 2025 | 7,495.00 |
| Dec 31, 2024 | 7,495.00 |
| Sep 30, 2024 | 7,495.00 |
| Jun 30, 2024 | 7,495.00 |
| Mar 31, 2024 | 5,796.00 |
| Dec 31, 2023 | 20,796.00 |
| Sep 30, 2023 | 20,619.00 |
| Jun 30, 2023 | 26,022.00 |
| Mar 31, 2023 | 11,238.00 |
| Dec 31, 2022 | 11,238.00 |
| Sep 30, 2022 | 11,103.00 |
| Jun 30, 2022 | 10,353.00 |
| Mar 31, 2022 | 9,865.00 |
| Dec 31, 2021 | 9,865.00 |
| Sep 30, 2021 | 9,865.00 |
API Access
Annovis Bio Other Non-Current Assets API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=other-non-current-assets&ticker=ANVS&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "other-non-current-assets", "ticker": "ANVS", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=other-non-current-assets&ticker=ANVS&period=max&api_key=YOUR_API_KEY");
const data = await res.json();